DCVC (Data Collective) — 2023 Investments
4 investments dated 2023 · listed companies and verified rows first · show all
Kanvas Bio operates a full-stack microbiome drug discovery platform, using a spatial mapping engine to image host-microbiome interactions and in-house manufacturing to produce live biotherapeutics.
BiotechDeep TechHealthtechMonmouth Junction, US
Matthew Cheng(Executive Officer, Director)Hao Shi(Executive Officer, Director)Iwijn De Vlaminck(Executive Officer, Director)
BoardJustin Smithline(Director)in
Board seatJason Pontin· per SEC Form D
Co-investorsBascom VenturesBoutique Venture PartnersFemHealth VenturesGermin8 VenturesKicker VenturesPangaea Ventures Us Inc.+2 more
Reality Defender develops an AI platform for detecting deepfakes and synthetic media, serving enterprise organizations to prevent fraud and impersonation.
AI & Machine LearningCybersecurityDefense TechEnterprise SoftwareSaaSNew York City, US
Ben Colman(CEO & Co-Founder)inGaurav Bharaj(Co-founder)Ali Shahriyari(Director)Lars Buttler(Founder)Milos Fulton(Executive Officer)
BoardAlexander Ross(Director)in
Board seatAli Tamaseb· per SEC Form D
Co-investorsAmino CapitalArgon VenturesBooz Allen VenturesEvolution VC PartnersEx/AnteFPV+8 more
ShennonBio develops immunotherapy technologies using microfluidic engineering, computational biology, and immunology to advance T cell engineering for cancer treatment.
AI & Machine LearningBiotechDeep TechMedical DevicesSan Francisco, US
Li Sun, PhD(Founder/CEO)inLI SUN(Executive Officer, Director)
Board seatJames Hardiman· per SEC Form D
Co-investorsAV8 VenturesFuture VenturesNextGen Venture PartnersSamos InvestmentsFoundation Capital
BiotechMenlo Park, US
Brett Ewald(Executive Officer)Umesh Gangadharmath(Executive Officer)Istvan Molnar(Executive Officer)Yunfei Zhu(Executive Officer)Ana Kusnetzow(Executive Officer)Scott Struthers(Director)
Co-investorsFrazier Life Sciences
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.